Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience

Gelibter, S; Pirro, F; Saraceno, L; Susani, E; Moioli, MC; Puoti, M; Agostoni, EC; Protti, A

Gelibter, S (通讯作者)，ASST Grande Osped Metropolitano Niguarda, Neurol & Stroke Unit, Dept Neurosci, Piazza Osped Maggiore 3, I-20162 Milan, Italy.

JOURNAL OF NEUROIMMUNOLOGY, 2023; 383 ():

Abstract

Background: B-cell-depleting treatments, such as ocrelizumab and rituximab (anti-CD20), reduce humoral response to SARS-CoV-2 in people with Multiple ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索